You just read:

Clementia Pharmaceuticals Initiates First Prospective Natural History Study in Patients with Fibrodysplasia Ossificans Progressiva (FOP)

News provided by

Clementia Pharmaceuticals, Inc.

17 Dec, 2014, 12:30 GMT